Prostate Cancer - Results from #24720

Intraductal carcinoma of the prostate: Precursor or aggressive phenotype of prostate cancer? - Abstract September 26, 2012

Superior vena cava syndrome as a presentation of metastatic prostate cancer - Abstract September 25, 2012

Farming, reported pesticide use, and prostate cancer - Abstract September 25, 2012

Genetic heterogeneity in Finnish hereditary prostate cancer using ordered subset analysis - Abstract September 25, 2012

Tumour characteristics, oncological and functional outcomes in patients aged ≥ 70 years undergoing radical prostatectomy - Abstract September 25, 2012

PSA testing in general practice - Abstract September 25, 2012

Early diagnosis and treatment is crucial for neurological recovery after surgery for metastatic spinal cord compression in prostate cancer - Abstract September 25, 2012

Denosumab for the treatment of cancer therapy-induced bone loss and prevention of skeletal-related events in patients with solid tumors - Abstract September 25, 2012

Cost-effectiveness analysis of stereotactic body radiation therapy versus intensity-modulated radiation therapy: An emerging initial radiation treatment option for organ-confined prostate cancer - Abstract September 25, 2012

Docetaxel plus prednisone versus mitoxantrone plus prednisone as first-line chemotherapy for metastatic hormone-refractory prostate cancer: Long-term effects and safety - Abstract September 25, 2012

African American prostate cancer survivors' treatment decision-making and quality of life - Abstract September 24, 2012

Transrectal biopsy scheme can predict incorrect histological grading in prostate cancer - Abstract September 24, 2012

Completeness of prostate cancer staging in the Danish Cancer Registry, 2004-2009 - Abstract September 24, 2012

Docetaxel in combination with estramustine and prednisolone for castration-resistant prostate cancer - Abstract September 24, 2012

Family history of prostate cancer in a Black population - Abstract September 24, 2012

Effects of androgen deprivation therapy and bisphosphonate treatment on bone in patients with metastatic castration resistant prostate cancer: Results from the University of Washington rapid autopsy series - Abstract September 24, 2012

Validity of the recorded codes of gonadotropin-releasing hormone agonist treatment and orchiectomies in the Danish National Patient Registry - Abstract September 24, 2012

Diabetic nephropathy is associated with prostate-specific antigen levels in type 2 diabetes mellitus - Abstract September 24, 2012

The impact of prostate biopsy on urinary symptoms, erectile function, and anxiety - Abstract September 21, 2012

20-Year survival after radical prostatectomy as initial treatment for cT3 prostate cancer - Abstract September 21, 2012

Page 1237 of 1435